Entering text into the input field will update the search result below

OptiNose GAAP EPS of -$0.17 in-line, revenue of $20.86M beats by $0.17M

Mar. 07, 2023 7:03 AM ETOptiNose, Inc. (OPTN)By: Niloofer Shaikh, SA News Editor
  • OptiNose press release (NASDAQ:OPTN): Q4 GAAP EPS of -$0.17 in-line.
  • Revenue of $20.86M (-7.3% Y/Y) beats by $0.17M.
  • The company expects XHANCE net revenues for the full year of 2023 to be between $62.0 to $68.0 million. XHANCE net revenues attributable to a

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About OPTN

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
OptiNose, Inc.
Jushi Holdings Inc.
Scilex Holding Company
Ventyx Biosciences, Inc.
Esperion Therapeutics, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.